Physician profile
Phyllis B Wallo
NPI 1831228543
$1,753.22
in general payments reported to CMS, 2019-2025
9 companies · $23.32 in 2025
The $23.32 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.70 · 2020: $282 · 2021: $561 · 2022: $501 · 2023: $367 · 2025: $23.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $748.33 | 2021-2025 | Vraylar |
| Supernus Pharmaceuticals, INC. | $241.58 | 2021-2023 | Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $181.97 | 2021-2022 | |
| Allergan, INC. | $168.08 | 2020 | |
| Sunovion Pharmaceuticals INC. | $158.06 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $151.82 | 2020-2021 | |
| Lundbeck LLC | $42.47 | 2021-2022 | |
| Corium, LLC | $42.21 | 2022-2023 | Azstarys |
| Shire North American Group INC | $18.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phyllis Wallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.